Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats.
about
Neuroprotection and antioxidantsPeptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic-Ischemic EncephalopathyBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeNeuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemiaRadiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposureMelatonin promotes oligodendroglial maturation of injured white matter in neonatal rats.Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats.Hypoxic ischemic brain injury: Potential therapeutic interventions for the future.Melatonin attenuates intermittent hypoxia-induced lipid peroxidation and local inflammation in rat adrenal medulla.Melatonin Counteracts at a Transcriptional Level the Inflammatory and Apoptotic Response Secondary to Ischemic Brain Injury Induced by Middle Cerebral Artery Blockade in Aging RatsPropofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNKMelatonin: buffering the immune systemMelatonin-based therapeutics for neuroprotection in stroke.Effects of melatonin on cognitive impairment and hippocampal neuronal damage in a rat model of chronic cerebral hypoperfusionThe Effect of Circadian Melatonin Levels on Inflammation and Neurocognitive Functions Following Coronary Bypass SurgeryEffects of melatonin in experimental stroke models in acute, sub-acute, and chronic stagesPartial neural protection with prophylactic low-dose melatonin after asphyxia in preterm fetal sheep.Oxidative stress and its role in the pathogenesis of ischaemic stroke.Molecular chaperones and hypoxic-ischemic encephalopathyNeuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics.The role of neuroendocrine pathways in prognosis after stroke.Melatonin as an Antioxidant for Stroke Neuroprotection.Inflammation and the Silent Sequelae of Stroke.Treatment of acute cerebral ischemia using animal models: a meta-analysis.Melatonin inhibits matrix metalloproteinase-9 (MMP-9) activation in the lipopolysaccharide (LPS)-stimulated RAW 264.7 and BV2 cells and a mouse model of meningitis.Inhibitory effects of melatonin on the lipopolysaccharide-induced CC chemokine expression in BV2 murine microglial cells are mediated by suppression of Akt-induced NF-κB and STAT/GAS activity.Melatonin protects against transient focal cerebral ischemia in both reproductively active and estrogen-deficient female rats: the impact of circulating estrogen on its hormetic dose-response.Melatonin: Pharmacology, Functions and Therapeutic Benefits.Dual effects of melatonin on oxidative stress after surgical brain injury in rats.Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.Melatonin treatment reduces astrogliosis and apoptosis in rats with traumatic brain injury.Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats.Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model.Melatonin ameliorates hippocampal nitric oxide production and large conductance calcium-activated potassium channel activity in chronic intermittent hypoxia.Utility of melatonin to treat surgical stress after major vascular surgery--a safety study.Early reperfusion improves the recovery of contralateral electrophysiological diaschisis following focal cerebral ischemia in rats.The effects of long-term exposure of magnetic field via 900-MHz GSM radiation on some biochemical parameters and brain histology in rats.Optimal Percoll concentration facilitates flow cytometric analysis for annexin V/propidium iodine-stained ischemic brain tissues.Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway.The neuroprotective role of melatonin in neurological disorders.
P2860
Q26740098-D5653103-616F-459E-A594-026242E24A1EQ26768557-157D8AFC-2096-4043-B025-1E65022C7E0FQ26864317-9548AB02-05E0-465B-8168-82BFA97BC6DDQ26999039-C47BC83C-2D4F-4CA7-8F48-1CC2BE0FF3F6Q28387506-D1718046-D06C-4EE3-B7EF-96C36578305AQ33505669-C190276C-7BB2-4781-9A97-311E9740F518Q33841270-291D2297-FDB0-4E69-8083-635C655B7201Q34106605-3BD32FB6-0C36-4395-A40C-17CBFFCFA6B9Q34486843-8F070794-2BFE-4000-86E2-7E86B850C9EDQ36274443-9C7DB6E7-6E35-4FB4-ABA1-88F49A691C84Q36530160-2F61E0BD-4CC4-4D7F-88CE-0BA58AE4E04EQ36820644-4595B226-BDE3-4EE1-A977-BC4142695361Q36913537-0C3106B0-F288-4E47-8F44-D02C9647A2C9Q36953856-11E1DAFA-598A-449D-AFA9-7DA7702A7D3EQ36997436-25DE7A17-2534-492E-8F3F-160AB0FC638AQ37224612-E480F17A-0B51-4AEE-A587-4E126B3B2C47Q37459886-F5D07A49-AE00-4D2F-A4C1-3668BC394302Q37636340-AA587FCB-043E-424A-80AD-2007D5E9B163Q37655647-98A296E0-6469-470C-BF4E-B1BEF5B8AB9BQ38015254-467AD555-49F5-4AF0-BF0D-65588592F3EDQ38178714-A8D818DF-53E6-4490-B3A7-D46032194AE4Q38615563-156BBACF-FA7C-4CDC-A4C4-DB730A40B6CBQ38871034-4B2EF3A5-E2A6-4774-AA71-B635D9339D58Q39042361-AAFEF730-322D-491A-BF5E-BFEA71348192Q39382641-425AEED0-5521-4C58-842E-2507B3B5796EQ39416403-751F434F-E3D6-4934-96B1-F47DF4D77E39Q39611464-4E36B4AD-49B0-43A9-8A2B-254FFBADB39AQ41638855-0CF8B57C-F060-45BF-88AB-9B60DDA3E756Q41854597-4289648D-D46C-4157-B6C7-4DED000482BFQ41931096-042129EE-D471-4627-BA52-42A2FA211EF6Q42031531-F5E7F643-A37F-491B-B27C-7648F42C7BC2Q43458281-839D2AA0-F81F-44BE-80CC-CD4BB66E544CQ44099805-678541DC-EBE6-4742-A59B-D6731C2CA8EFQ46703463-5B7A065A-B778-4150-BCE9-A3AC9645E605Q46800761-56126899-4F9E-4919-B7CB-AB1CF9D09062Q48220995-2D21EF77-E0A6-43DB-B272-BC734A856B98Q48480483-3D216653-888F-478C-A1CD-AB6C1F7929BEQ48670169-FE415A47-A005-47E1-8EC6-462EA065028CQ49071796-4AD31361-CA03-4D1A-91A3-8938E6F3480BQ53396094-5A8C8B78-D5EA-421C-966B-AEC027E87751
P2860
Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Intravenous administration of ...... cal cerebral ischemia in rats.
@en
Intravenous administration of ...... cal cerebral ischemia in rats.
@nl
type
label
Intravenous administration of ...... cal cerebral ischemia in rats.
@en
Intravenous administration of ...... cal cerebral ischemia in rats.
@nl
prefLabel
Intravenous administration of ...... cal cerebral ischemia in rats.
@en
Intravenous administration of ...... cal cerebral ischemia in rats.
@nl
P2093
P2860
P921
P1476
Intravenous administration of ...... ocal cerebral ischemia in rats
@en
P2093
Chien-Chih Huang
E-Jian Lee
Hung-Yi Chen
I-Ping Yang
Ming-Yang Lee
Shur-Tzu Chen
Tian-Shung Wu
Tsung-Ying Chen
Yun-Shang Hsu
P2860
P304
P356
10.1111/J.1600-079X.2007.00420.X
P577
2007-04-01T00:00:00Z